Clearside Biomedical

Filed a patent for "compositions comprising axitinib and methods of treating ocular disorders" on Tue, July 18, 2023

Filed a patent for "methods for treating ocular disorder with integrin antagonist composition" on Mon, April 24, 2023

Filed a patent for "compositions and methods for treating macular edema associated with uveitis" on Fri, July 8, 2022

Filed a patent for "systems, devices, and methods for needle-less ocular injections" on Fri, July 15, 2022

Filed a patent for "compositions comprising axitinib and methods of treating ocular disorders" on Thu, March 23, 2023

Filed a patent for "compositions and methods for treating ocular disorders" on Thu, June 29, 2023

Filed a patent for "apparatus and methods for ocular injection" on Thu, May 25, 2023

Filed a patent for "ocular injector and methods for accessing suprachoroidal space of the eye" on Thu, November 23, 2023